J84.81

Clinical Causes: The precise cause of lymphangioleiomyomatosis is unknown. It involves a proliferation of abnormal smooth muscle cells that invade lung tissue and lymphatic vessels. Genetic factors may play a role; some cases are linked to mutations in the TSC1 or TSC2 genes, associated with tuberous sclerosis complex. Hormonal influences: estrogen appears to promote disease progression, which may explain the predominance in women of reproductive age.

Key Symptoms: Shortness of breath, especially with exertion Persistent cough Chest pain or discomfort Spontaneous pneumothorax (collapsed lung) Chylous pleural effusions (accumulation of lymphatic fluid in the chest) Fatigue Increased frequency of respiratory infections Coughing up blood (hemoptysis), although less common

Diagnosis Path: Diagnosing lymphangioleiomyomatosis involves a combination of clinical evaluation, imaging techniques, and laboratory studies. Common steps include: - **Medical history review and physical examination** focusing on respiratory symptoms. - **High-resolution computed tomography (HRCT) scans** of the chest, which reveal characteristic cystic changes throughout the lungs. - **Pulmonary function tests** to assess lung capacity and airflow. - **Blood tests** to check for underlying genetic factors or related conditions. - **Lymphatic and abdominal imaging** if lymphatic involvement is suspected. - **Lung biopsy**, in some cases, may be necessary to confirm diagnosis by identifying abnormal smooth muscle cell proliferation. - **Evaluation for tuberous sclerosis**, as some patients present with this associated condition.

Treatment Protocols: While there is no cure for lymphangioleiomyomatosis, several treatment strategies aim to manage symptoms and slow disease progression: - **Mammalian target of rapamycin (mTOR) inhibitors** such as sirolimus or everolimus, which help inhibit abnormal cell growth. - **Management of pneumothorax** with procedures like chest tube insertion or pleurodesis. - **Supportive therapies** including oxygen therapy to assist with breathing difficulties. - **Lung transplantation**, considered for advanced cases where lung function is severely compromised. - **Hormonal therapy**: The role of hormones like progesterone is controversial; some treatments involve hormonal suppression, but evidence of effectiveness is limited. - **Regular monitoring** to detect disease progression and manage associated complications.